How effective is temozolomide for treating pituitary tumours and when should it be used?
出版年份 2016 全文链接
标题
How effective is temozolomide for treating pituitary tumours and when should it be used?
作者
关键词
Pituitary, Temozolomide, Review, Aggressive, Methylguanine-DNA methyltransferase (MGMT)
出版物
Pituitary
Volume 20, Issue 2, Pages 261-266
出版商
Springer Nature
发表日期
2016-09-03
DOI
10.1007/s11102-016-0745-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Is there a role for early chemotherapy in the management of pituitary adenomas?
- (2016) Andrew L. Lin et al. NEURO-ONCOLOGY
- Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
- (2015) Daniel Bengtsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The role of temozolomide in the treatment of aggressive pituitary tumors
- (2015) James K. Liu et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center
- (2015) Filippo Ceccato et al. JOURNAL OF NEURO-ONCOLOGY
- Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas
- (2015) Marco Losa et al. JOURNAL OF NEURO-ONCOLOGY
- Aggressive Pituitary Tumors
- (2015) Eleftherios Chatzellis et al. NEUROENDOCRINOLOGY
- Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment
- (2015) Mariana Campderá et al. Pituitary
- Novel MSH6 Mutations in Treatment-Naive Glioblastoma and Anaplastic Oligodendroglioma Contribute to Temozolomide Resistance Independently of MGMT Promoter Methylation
- (2014) S. A. Nguyen et al. CLINICAL CANCER RESEARCH
- Aggressive pituitary adenomas—diagnosis and emerging treatments
- (2014) Antonio Di Ieva et al. Nature Reviews Endocrinology
- DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors
- (2013) Toshio Hirohata et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide in the management of dopamine agonist-resistant prolactinomas
- (2012) B. C. Whitelaw et al. CLINICAL ENDOCRINOLOGY
- Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment
- (2012) Gérald Raverot et al. CLINICAL ENDOCRINOLOGY
- Temozolomide in aggressive pituitary adenomas and carcinomas
- (2012) LD Ortiz et al. Clinics
- Treatment of pituitary neoplasms with temozolomide
- (2011) Gianluca Marucci CANCER
- Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
- (2011) Ann I. McCormack et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas
- (2011) Fateme Salehi et al. JOURNAL OF NEURO-ONCOLOGY
- A Mechanism of Acquiring Temozolomide Resistance During Transformation of Atypical Prolactinoma Into Prolactin-Producing Pituitary Carcinoma: Case Report
- (2011) Mineko Murakami et al. NEUROSURGERY
- Treatment of pituitary neoplasms with temozolomide
- (2010) Luis V. Syro et al. CANCER
- Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases
- (2010) Marco Losa et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- SOM230 (Pasireotide) and Temozolomide Achieve Sustained Control of Tumour Progression and ACTH Secretion in Pituitary Carcinoma with Widespread Metastases
- (2010) H. Bode et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
- (2010) Zachary M. Bush et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
- (2010) Gérald Raverot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
- (2009) Jennifer A. Quinn et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanisms of Disease: temozolomide and glioblastoma—look to the future
- (2008) Maciej M Mrugala et al. Nature clinical practice. Oncology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started